Edwards Lifesciences Corp. (EW)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Edwards Lifesciences Corp. (EW)
Company Performance

Current Price

as of Dec 03, 2024

$70.20

P/E Ratio

10.17

Market Cap

$41.6B

Loading...
Description

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Metrics

Overview

  • HQIrvine, CA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerEW
  • Price$70.2-0.47%

Trading Information

  • Market cap$41.60B
  • Float98.30%
  • Average Daily Volume (1m)4,660,115
  • Average Daily Volume (3m)6,020,851
  • EPS$6.95

Company

  • Revenue$5.87B
  • Rev growth (1yr)-8.54%
  • Net income$363.50M
  • Gross margin79.33%
  • EBITDA margin30.40%
  • EBITDA$411.80M
  • EV$35.79B
  • EV/Revenue6.09
  • P/E10.17
  • P/S7.18
  • P/B4.36
Documents